danumed Extension Set for Gastrostomy Button
Danumed Medizintechnik GmbH · Decision date Sep 10, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 10, 2026 for the danumed Extension Set for Gastrostomy Button, submitted by Danumed Medizintechnik GmbH of Regensburg, Germany, under 510(k) number K260110. The device is regulated under 21 CFR 876.5980 as a Class II gastrointestinal tube and accessory, with primary product code PIF and subsequent product code KNT; the review panel and medical specialty are Gastroenterology/Urology. SESE means the device was cleared for marketing, not granted premarket approval.
The FDA database lists the submission as a traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan. The clearance letter states substantial equivalence to legally marketed predicate devices for the indications for use in the enclosure. The source does not include the indications for use text, the predicate devices identified, or any performance data, so the clinical basis for the determination is not described here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Sep 10, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260110
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Danumed Medizintechnik GmbH
- Product code
- PIF
- Decision code
- SESE
- Decision date
- Sep 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Gastrointestinal Tubes With Enteral Specific Connectors.
- Applicant
- Danumed Medizintechnik GmbH
- Product code
- PIF
- FDA device class
- 2
FDA decision timeline
K260110 received
Application receipt date recorded by FDA.
K260110 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Danumed Medizintechnik GmbH
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Regensburg
Sources and methodology
- Original FDA record: K260110
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records